FDA Inspection 1087099 — REI Division Brooke Army Med Cntr
The FDA completed an inspection of REI Division Brooke Army Med Cntr on March 18, 2019 in Jbsa Ft Sam Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 18, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Jbsa Ft Sam Houston, TX (United States)